Can HCV be eliminated among HIV-infected MSM in Berlin? Modeling a setting with increasing incidence and high treatment rates
Natasha K. Martin(University of California San Diego), Patrick Ingiliz(Hôpitaux Universitaires Henri-Mondor), S. Mauss(Center for HIV and Hepatogastroenterology), Tracey Lutz, A. Boyd, Knud Schewe(Robert Koch Institute), Jürgen K. Rockstroh(University of Bonn), Christoph Boesecke(University Hospital Bonn), Steen Bach Christensen, Axel Baumgarten, Matthias an der Heiden(Robert Koch Institute), A Thielen, Klaus Jansen(Robert Koch Institute)
Cited by 4
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Epidemic Profile of Shiga-Toxin–Producing<i>Escherichia coli</i>O104:H4 Outbreak in Germany
|New England Journal of Medicine|2011|1.1k
German Outbreak of<i>Escherichia coli</i>O104:H4 Associated with Sprouts
|New England Journal of Medicine|2011|718
MAIT cells are activated during human viral infections
|Nature Communications|2016|526
Influence of Hepatitis C Virus Infection on HIV‐1 Disease Progression and Response to Highly Active Antiretroviral Therapy
|The Journal of Infectious Diseases|2005|385